Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,209 | -29,216 | -25,427 | 3,387 | N/A |
| Depreciation Amortization | 1,580 | 1,688 | 376 | N/A | N/A |
| Accounts payable and accrued liabilities | -628 | -6,170 | 1,624 | 64 | N/A |
| Other Working Capital | -1,698 | -6,242 | 3,569 | -291 | N/A |
| Other Operating Activity | 3,261 | 12,957 | 6,644 | -4,243 | 0 |
| Operating Cash Flow | $-19,694 | $-26,983 | $-13,214 | $-1,083 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -230,000 | N/A |
| PPE Investments | -16 | -585 | -428 | N/A | N/A |
| Other Investing Activity | 0 | 107 | -66 | 0 | 0 |
| Investing Cash Flow | $-16 | $-478 | $-494 | $-230,000 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 1,250 | 500 | 0 | N/A |
| Debt Issued | 3,800 | 2,000 | 1,000 | N/A | N/A |
| Debt Repayment | -1,582 | -101 | -81 | N/A | N/A |
| Common Stock Issued | 25,010 | 281 | 114 | 230,025 | N/A |
| Other Financing Activity | 137 | 25,614 | 10,554 | 2,121 | 0 |
| Financing Cash Flow | $27,365 | $29,044 | $12,087 | $232,146 | $N/A |
| Exchange Rate Effect | -13 | -6 | -26 | N/A | N/A |
| Beginning Cash Position | 2,167 | 590 | 2,237 | 0 | N/A |
| End Cash Position | 9,809 | 2,167 | 590 | 1,063 | N/A |
| Net Cash Flow | $7,642 | $1,577 | $-1,647 | $1,063 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,694 | -26,983 | -13,214 | -1,083 | N/A |
| Capital Expenditure | -16 | -585 | -428 | N/A | N/A |
| Free Cash Flow | -19,710 | -27,568 | -13,642 | -1,083 | 0 |